Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

A visit to the stroke belt of the United States.

Bathala L.

J Neurosci Rural Pract. 2012 Sep;3(3):426-8. doi: 10.4103/0976-3147.102653.

2.
3.

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV.

Arch Neurol. 2001 Dec;58(12):2009-13.

PMID:
11735774
4.

Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.

Leung TW, Yu SC, Wong KS.

Int J Stroke. 2011 Aug;6(4):312-4. doi: 10.1111/j.1747-4949.2011.00634.x.

PMID:
21745340
6.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
7.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
8.

Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.

Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.

Isr Med Assoc J. 2004 Feb;6(2):70-4.

10.
12.

Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.

Bourekas EC, Slivka AP, Shah R, Sunshine J, Suarez JI.

Neurosurgery. 2004 Jan;54(1):39-44; discussion 44-6.

PMID:
14683539
13.

Role of tissue plasminogen activator in acute ischemic stroke.

Hatcher MA, Starr JA.

Ann Pharmacother. 2011 Mar;45(3):364-71. doi: 10.1345/aph.1P525. Review.

PMID:
21386027
14.

Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.

Uchino K, Massaro L, Jovin TG, Hammer MD, Wechsler LR.

J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):417-23. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.013.

PMID:
21051004
15.

Advances in revascularization for acute ischemic stroke treatment: an update.

Eesa M, Schumacher HC, Higashida RT, Meyers PM.

Expert Rev Neurother. 2011 Aug;11(8):1125-39. doi: 10.1586/ern.11.102. Review.

PMID:
21797654
16.

Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.

Georgiadis D, Engelter S, Tettenborn B, Hungerbühler H, Luethy R, Müller F, Arnold M, Giambarba C, Baumann CR, von Büdingen HC, Lyrer P, Baumgartner RW.

Circulation. 2006 Jul 18;114(3):237-41.

17.

Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?

Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF.

J Stroke Cerebrovasc Dis. 2010 Mar;19(2):116-20. doi: 10.1016/j.jstrokecerebrovasdis.2009.03.019.

PMID:
20189087
18.

Trombolysis in acute stroke.

Schwammenthal Y, Tsabari R, Bakon M, Orion D, Merzeliak O, Tanne D.

Isr Med Assoc J. 2006 Nov;8(11):784-7.

19.
20.

Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.

Muengtaweepongsa S, Dharmasaroja P, Kummark U.

J Stroke Cerebrovasc Dis. 2012 Jan;21(1):42-6. doi: 10.1016/j.jstrokecerebrovasdis.2010.03.017.

PMID:
22225863

Supplemental Content

Support Center